During Monday’s Current trade, Shares of AmerisourceBergen Corp. (NYSE:ABC), gain 0.19% to $109.67.
AmerisourceBergen Corporation (ABC) declared that it plans to release its results for the Third Quarter Fiscal 2015 on Thursday, July 23, 2015 preceding to the opening of trading on the New York Stock Exchange. The Company will host a conference call to talk about the results at 11:00 a.m. Eastern Time on July 23, 2015.
AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, counting acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Shares of HomeAway, Inc. (NASDAQ:AWAY), inclined 1.14% to $31.01, during its current trading session.
HomeAway, Inc. (AWAY), the world leader in vacation rentals, declared a partnership with Dubai’s Department of Tourism and Commerce Marketing (Dubai Tourism) to promote Dubai’s vacation homes to the world and Dubai as a destination to HomeAway(R) travelers.
The relationship enhances HomeAway’s position in the Middle East and opens Dubai up to the millions of families and groups of travelers from around the globe who book their vacation rental accommodations via HomeAway. HomeAway and Dubai Tourism will work together to strengthen the vacation homes sector in Dubai by raising awareness of and providing support to the many licensed vacation homes operators in the Emirate. Additionally, the two organizations are planning joint traveler-focused campaigns, leveraging Dubai’s world-class marketing team and HomeAway’s global strength in the vacation homes sector.
HomeAway, Inc., together with its auxiliaries, operates an online vacation rental property marketplace that enables property owners and managers to market properties for rental to vacation travelers. The company’s portfolio comprises vacation rental Websites, such as HomeAway.com, VRBO.com, and VacationRentals.com in the United States; HomeAway.co.uk and OwnersDirect.co.uk in the United Kingdom; HomeAway.de in Germany; Abritel.fr and Homelidays.com in France; HomeAway.es and Toprural.com in Spain; AlugueTemporada.com.br in Brazil; HomeAway.com.au and Stayz.com.au in Australia; and Bookabach.co.nz in New Zealand.
Noah Holdings Limited (ADR) (NYSE:NOAH), during its Monday’s current trading session gained 1.67% to $25.58.
Noah Holdings Limited (NOAH), a leading wealth administration services provider with a focus on global wealth investment and asset allocation services for high net worth individuals and enterprises in China, recently declared that its board of directors has approved a share repurchase program, effective right away, which authorizes the Company to repurchase up to US$50 million worth of its issued and outstanding American Depositary Shares (“ADSs”) over the course of one year.
In addition to the Company’s share repurchase program, three executive directors, Ms. Jingbo Wang, Mr. Zhe Yin, and Ms. Chia-Yue Chang, all intend to purchase Noah’s ADSs on the open market.
The repurchases will be made on the open market at prevailing market prices or in block trades and subject to restrictions regardingvolume, price and timing. The timing and extent of any purchases will depend upon market conditions, the trading price of the ADSs, the nature of other investment opportunities presented to the Company, the Company’s cash flows and predictable cash flows, general economic conditions and other factors. The Company and executive directors may effect buyback transactions following Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Noah Holdings Limited, through its auxiliaries, operates as a wealth administration service provider with focus on wealth investment and asset allocation services for high net worth individuals and enterprises in the People’s Republic of China.
Finally, Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), gained 3.26%, to $5.04.
Catalyst Pharmaceuticals, Inc. (CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, declared the appointment of Gary Ingenito, M.D., Ph.D, as Chief Medical Officer. Dr. Ingenito has more than 25 years of experience leading pharmaceutical development for drugs and biologics. In this new role, he will oversee all clinical development programs, medical affairs, regulatory and other related functions. Dr. Ingenito will report to Dr. Steven Miller, Catalyst’s Chief Operating Officer and Chief Scientific Officer. Following Dr. Ingenito’s joining Catalyst, the current Chief Medical Officer, Charles Gorodetzky, M.D., Ph.D, will continue to serve as a consultant to the company.
Catalyst Pharmaceuticals, Inc., a development-stage biopharmaceutical company, focuses on the development and commercialization of prescription drugs targeting rare (orphan) neurological diseases and disorders. The company offers Firdapse, a proprietary form of amifampridine phosphate, which is in Phase III clinical trial for the treatment of Lambert-Eaton Myasthenic Syndrome.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
